Among methyltransferases in ovarian cancer, the Enhancer of Zeste 2 (EZH2)—also known as Polycomb Repressive Complex 2 (PRC2)—has emerged as an important epigenetic regulator of ovarian cancer biology. Here, EZH2 is linked to ovarian cancer.